All In Biotech

Drug Trial Radar · NCT02160678

Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris

A Double-Blind,Randomized,Parallel-Group,Vehicle-Controlled,MulticenterStudy ComparingaGenericTazaroteneCream,0.1%toReference Listed Drug Tazorac® Cream, 0.1% and Both Active Treatments to Vehicle Control in the Treatment of Acne Vulgaris

Last checked: Nov 19, 2026Latest source record: Nov 3, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,741 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,741

Actual

Start

May 2014

Primary completion

Jul 2015

Study completion Jul 2015

Sponsor

Lead sponsor
G & W Laboratories Inc.Industry
Sponsor type
Industry
First posted
Jun 11, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 12 years, up to 40 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To compare the safety and efficacy profiles of Tazarotene Cream, 0.1 % to the reference listed drug Tazorac® (tazarotene) Cream, 0.1 % in order to demonstrate bioequivalence, and to demonstrate superiority of the 2 active creams over that of the cream vehicle (placebo) in the treatment of acne vulgaris.

Conditions

  • Acne Vulgaris

Interventions

  • VehicleDrug

    Cream Vehicle (placebo) (G \& W Laboratories, Inc.)- vehicle

  • Tazarotene Cream, 0.1 %Drug

    Tazarotene Cream, 0.1 % (G \& W Laboratories, Inc.) - test product

  • Tazorac Cream, 0.1%Drug

    Tazorac Cream, 0.1% (Allergan, Inc.) - reference product

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluation of equivalence of the test product to the reference productTime frame: Week 12
  2. Evaluation of superiorityTime frame: Week 12

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Altman Dermatology Associates

    Arlington Hts., Illinois

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.